Diabetes Action Canada to have its first External Review

As Diabetes Action Canada enters its fourth year of funding, it is necessary to critically evaluate our programs and progress to plan for the next phase of our SPOR Network.  We are already well underway in conducting an internal network evaluation, led by Dr. Valeria Rac at the THETA Collaborative, University of Toronto and University Health Network,  and Dr. Mathieu Ouimet at the Université Laval.  The Diabetes Action Canada leadership and Steering Council have invited three reviewers from Canada and the USA to evaluate our research Network in November 2019, that will provide an independent perspective about our performance.  The reviewers will receive  a summary of our achievements against stated goals as well as our assessment of barriers to success. In addition, they will obtain an initial report of our network evaluation detailing the growth and impact of our internal and external collaborations.  We anticipate that this external review will result in important advice about strategic planning for our next phase of Diabetes Action Canada and possible SPOR Network renewal.  Below is a list of the four external reviewers and links to their biographies.

Dr Cindy Bell, PhD
Executive Vice President, Corporate Development, Genome Canada
Mother of two daughters with T1D
Bio

Dr. Diane Bild, MD, MPH
Former Chief Science Officer
Patient-Centered Outcomes Research Institute (PCORI) – USA
Bio

Dr. Hertzel Gerstein, MD, MSc, FRCPC
Professor of Medicine, McMaster University and Hamilton Health Sciences
Population Health Research Institute Chair in Diabetes
Director, Division of Endocrinology & Metabolism, McMaster University
Director, Diabetes Care and Research Program,
Deputy Director, Population Health Research Institute
Bio 

Dr. Louise Potvin
Director, Institute for Public Health Research,
Professor, Department of Social and Preventive Medicine, School of Public Health,
University of Montreal
Bio


Stay updated with News and Events